Medical News

RSS

Penn Medicine receives $12.3 million NIH grant to study FLASH radiotherapy for cancer

With more than $12 million in new funding from the National Institutes of Health, the Abramson Cancer Center at the University of Pennsylvania will build on its preclinical research of an emerging form of radiation that provides ultra-fast doses - of under a second, compared to several minutes with conventional radiation - and shows promise of greater protection of normal tissue, thereby minimizing toxic effects to the body.

1 Mar 2022

Intensive treatment for patients with Crohn's disease found to be safe

Intensive treatment for patients with Crohn's disease showed no safety differences compared to the current standard of care, according to a trial published in the journal Gastroenterology.

1 Mar 2022

U of U Health researchers lead a $22-million nationwide clinical trial for rare brain disorder

University of Utah Health researchers are leading a five-year, $22-million nationwide clinical trial for NMDA receptor encephalitis––a type of autoimmune encephalitis that prompts the immune system to mistakenly attack the brain, causing confusion, memory loss, seizures, and symptoms similar to bipolar disorder and other psychiatric conditions.

1 Mar 2022

Vapers, hookah smokers may expose the nose and sinuses to more emissions than cigarette smokers

People who smoke e-cigarette and hookah are more than twice as likely to exhale particles through their nose compared with people who smoke cigarettes, who favor exhaling the emissions from their mouth, a new study shows.

1 Mar 2022

Government to revoke regulations making COVID-19 vaccination as a condition of deployment

Regulations making COVID-19 vaccination a condition of deployment in health and social care will be revoked on Tuesday 15 March, the Health and Social Care Secretary has confirmed today (Tuesday 1 March).

1 Mar 2022

30-60 minutes/week of muscle strengthening activities may lower mortality risk

Between 30 and 60 minutes of muscle strengthening activity every week is linked to a 10-20% lower risk of death from all causes, and from cardiovascular disease, diabetes, and cancer, in particular, finds a pooled data analysis of the available evidence, published online in the British Journal of Sports Medicine.

1 Mar 2022

AI and machine learning could improve cancer diagnosis through biomarker discovery

Artificial intelligence (AI), deep learning (DL), and machine learning (ML) have transformed many industries and areas of science.

1 Mar 2022

Cow's milk protein can trigger inflammation in multiple sclerosis sufferers

Multiple sclerosis sufferers often complain of more severe disease symptoms after consuming dairy products. Researchers at the Universities of Bonn and Erlangen-Nuremberg have now found a possible cause for this.

1 Mar 2022

Face masks can play a crucial role in reducing the spread of Covid infection

An international research team from universities including Chalmers University of Technology, Sweden, the University of Padua and the University of Udine in Italy, and the University of Vienna, Austria, has developed a new theoretical model to better assess the risks of spreading viruses such as Covid-19 - with and without a face mask.

1 Mar 2022

€10 million ‘precision medicine’ research project launched to provide new insights into ALS

An ambitious academic, clinical and industry research programme that will provide new insights into our understanding of Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS), was launched today by Tánaiste and Irish Minister for Enterprise, Trade and Employment, Leo Varadkar T.D.

1 Mar 2022

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

A new study assessed the immunogenicity of messenger-ribonucleic acid vaccines to generate cross-reactive neutralizing antibodies against the SARS-CoV-2 Omicron variant in convalescent COVID-19 patients.

1 Mar 2022

Risk of death involving COVID-19 following infection from Omicron relative to Delta

Researchers conducted a retrospective study on a cohort of patients in England with SARS-CoV-2 positive test results.

1 Mar 2022

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

In a new study, researchers performed genomic sequencing of SARS-CoV-2-infected samples and aimed to identify the dominant variant, assess the mutation profile, and determine the sample-to-sequence turnover time.

1 Mar 2022

Impact of COVID-19 boosters on protection against SARS-CoV-2 infection in a highly vaccinated population

A recent study analyzed the impact of COVID-19 booster vaccines against the SARS-CoV-2 Omicron VOC in a vaccinated population.

1 Mar 2022

Study explores dictionary learning-based bridge integration method for data harmonization of single-cell analysis

In a new study, researchers developed and elucidated a ‘bridge integration’ method to harmonize single-cell ribonucleic acid sequencing datasets.

1 Mar 2022

Using AI to detect antibiotic resistance

In this interview, we speak to Professor Karsten Borgwardt and Professor Adrian Egli about their latest research that used AI to predict antibiotic resistance.

1 Mar 2022

INTEGRA’s VOYAGER offers effective pipetting for plant-based transient expression and bacteriocin testing applications

Researchers at NOMAD Bioscience GmbH are taking advantage of the remarkable liquid handling capabilities of INTEGRA’s VOYAGER adjustable tip spacing pipette for the preparation and dispensing of media and gels.

From INTEGRA Biosciences 1 Mar 2022

Researchers explore the impact of COVID-19 lockdown on loneliness and cortisol levels

A recent study assessed the impact of social isolation and loneliness during coronavirus disease 2019 lockdown.

1 Mar 2022

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Mercia Asset Management, Calculus Capital, Downing Ventures and BGF scale joint investment in latest fundraise.

From MIP Discovery 1 Mar 2022

Association between booster breakthrough infections with the SARS-CoV-2 Omicron variant and time-since-vaccination

A recent study assessed the waning efficacy of the BioNTech/Pfizer BNT162b2 mRNA vaccine against the SARS-CoV-2 Omicron VOC.

1 Mar 2022

Medical News

Penn Medicine receives $12.3 million NIH grant to study FLASH radiotherapy for cancer

Intensive treatment for patients with Crohn's disease found to be safe

U of U Health researchers lead a $22-million nationwide clinical trial for rare brain disorder

Vapers, hookah smokers may expose the nose and sinuses to more emissions than cigarette smokers

Government to revoke regulations making COVID-19 vaccination as a condition of deployment

30-60 minutes/week of muscle strengthening activities may lower mortality risk

AI and machine learning could improve cancer diagnosis through biomarker discovery

Cow's milk protein can trigger inflammation in multiple sclerosis sufferers

Face masks can play a crucial role in reducing the spread of Covid infection

€10 million ‘precision medicine’ research project launched to provide new insights into ALS

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

Risk of death involving COVID-19 following infection from Omicron relative to Delta

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

Impact of COVID-19 boosters on protection against SARS-CoV-2 infection in a highly vaccinated population

Study explores dictionary learning-based bridge integration method for data harmonization of single-cell analysis

Using AI to detect antibiotic resistance

INTEGRA’s VOYAGER offers effective pipetting for plant-based transient expression and bacteriocin testing applications

Researchers explore the impact of COVID-19 lockdown on loneliness and cortisol levels

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Association between booster breakthrough infections with the SARS-CoV-2 Omicron variant and time-since-vaccination

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News